Levels of PACAP are increased in blood tests during migraine; infusing PACAP triggers migraines through vasodilation, neurogenic inflammation, and nociception; and there is some data indicating that blocking the PACAP pathway can reduce monthly migraine burden [82]. Here, ADCYAP1 is linked to migraine disorder.